Evaluation of Synergistic Anti-plaque Activity of Salvadora Persica L. and Green Tea: A Clinical Comparative Study
ESAA
1 other identifier
interventional
14
0 countries
N/A
Brief Summary
Accumulation of dental plaque may result in negative effects on the tooth and tooth supporting periodontal tissue. In addition, it contributes to the development of caries and periodontal diseases. Therefore, an effective dental plaque control is essential for maintaining good oral hygiene. Mechanical plaque control has its limitation thus chemical plaque control may be used as an adjunct in dental plaque control. Various types of medicinal plants can be utilized as stable, safe and biologically active plant-derived galenicals as alternative to synthetic mouth wash. Among these plants, Salvadora persica L. (Sp) root sticks and green tea (Gt) aqueous extracts were reported to have anti-microbial activity against many oral bacteria. The objective of this study was to investigate the efficacy of the combination of Gt aqueous extract and Sp aqueous extract as a synergistic anti-bacterial and anti-adherence efficacy against primary plaque colonizers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2 healthy-volunteers
Started Feb 2015
Shorter than P25 for phase_2 healthy-volunteers
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 3, 2015
CompletedFirst Posted
Study publicly available on registry
December 8, 2015
CompletedDecember 8, 2015
December 1, 2015
4 months
December 3, 2015
December 7, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean amount plaque between different DTC1 and placebo comparators i.e. Oradex and distilled water, as anti-plaque agent following 24 hrs plaque regrowth clinical trial by means of modified Quigely Hein Plaque Index [Turesky, 1970].
24 hours
Study Arms (3)
DTC1 mouth wash
ACTIVE COMPARATOR15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Oradex mouth wash
PLACEBO COMPARATOR15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Distilled water
PLACEBO COMPARATOR15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Interventions
15ml DTC1 twice a day, rinse for 30sec refrain from eating or drinking for 30min
15ml Chlorhexidine gluconate 0.12% (w/v) twice a day, rinse for 30sec refrain from eating or drinking for 30min
15ml distilled water twice a day, rinse for 30sec refrain from eating or drinking for 30min
Eligibility Criteria
You may qualify if:
- Participants should be medically healthy.
- Participants should have more than 20 teeth.
You may not qualify if:
- Participants who have active cavity caries and/or periodontal disease.
- Participants who have ongoing orthodontic treatment.
- Participants who have been on antibiotics within the past 4 months.
- Participants who require prophylactic antibiotic coverage.
- Participants who have been on systemic or topical non-steroidal anti-inflammatory drugs for the past 4 months.
- Participants who are pregnant or intended to and lactating mother.
- Participants who have heart valve replacement and have known intolerance or allergy to mouth rinses.
- Participants who have any systemic disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (16)
Addy M, Moran J, Newcombe R, Warren P. The comparative tea staining potential of phenolic, chlorhexidine and anti-adhesive mouthrinses. J Clin Periodontol. 1995 Dec;22(12):923-8. doi: 10.1111/j.1600-051x.1995.tb01796.x.
PMID: 8613560BACKGROUNDAllison DG, Gilbert P. Modification by surface association of antimicrobial susceptibility of bacterial populations. J Ind Microbiol. 1995 Oct;15(4):311-7. doi: 10.1007/BF01569985.
PMID: 8605070BACKGROUNDBaehni PC, Takeuchi Y. Anti-plaque agents in the prevention of biofilm-associated oral diseases. Oral Dis. 2003;9 Suppl 1:23-9. doi: 10.1034/j.1601-0825.9.s1.5.x.
PMID: 12974527BACKGROUNDChelli-Chentouf N, Tir Touil Meddah A, Mullie C, Aoues A, Meddah B. In vitro and in vivo antimicrobial activity of Algerian Hoggar Salvadora persica L. extracts against microbial strains from children's oral cavity. J Ethnopharmacol. 2012 Oct 31;144(1):57-66. doi: 10.1016/j.jep.2012.08.025. Epub 2012 Aug 29.
PMID: 22963838BACKGROUNDDhar V, Jain A, Van Dyke TE, Kohli A. Prevalence of gingival diseases, malocclusion and fluorosis in school-going children of rural areas in Udaipur district. J Indian Soc Pedod Prev Dent. 2007 Apr-Jun;25(2):103-5. doi: 10.4103/0970-4388.33458.
PMID: 17660647BACKGROUNDFarnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy. Bull World Health Organ. 1985;63(6):965-81.
PMID: 3879679BACKGROUNDHellden L, Camosci D, Hock J, Tinanoff N. Clinical study to compare the effect of stannous fluoride and chlorhexidine mouthrinses on plaque formation. J Clin Periodontol. 1981 Feb;8(1):12-6. doi: 10.1111/j.1600-051x.1981.tb02019.x.
PMID: 7019266BACKGROUNDIsmail AI, Szpunar SM. The prevalence of total tooth loss, dental caries, and periodontal disease among Mexican Americans, Cuban Americans, and Puerto Ricans: findings from HHANES 1982-1984. Am J Public Health. 1990 Dec;80 Suppl(Suppl):66-70. doi: 10.2105/ajph.80.suppl.66.
PMID: 9187585BACKGROUNDManganiello AD, Socransky SS, Smith C, Propas D, Oram V, Dogon IL. Attempts to increase viable count recovery of human supragingival dental plaque. J Periodontal Res. 1977 Mar;12(2):107-19. doi: 10.1111/j.1600-0765.1977.tb00113.x. No abstract available.
PMID: 138728BACKGROUNDRosan B, Lamont RJ. Dental plaque formation. Microbes Infect. 2000 Nov;2(13):1599-607. doi: 10.1016/s1286-4579(00)01316-2.
PMID: 11113379BACKGROUNDSofrata A, Brito F, Al-Otaibi M, Gustafsson A. Short term clinical effect of active and inactive Salvadora persica miswak on dental plaque and gingivitis. J Ethnopharmacol. 2011 Oct 11;137(3):1130-4. doi: 10.1016/j.jep.2011.07.034. Epub 2011 Jul 20.
PMID: 21798329BACKGROUNDSofrata A, Santangelo EM, Azeem M, Borg-Karlson AK, Gustafsson A, Putsep K. Benzyl isothiocyanate, a major component from the roots of Salvadora persica is highly active against Gram-negative bacteria. PLoS One. 2011;6(8):e23045. doi: 10.1371/journal.pone.0023045. Epub 2011 Aug 1.
PMID: 21829688BACKGROUNDTeles RP, Teles FR. Antimicrobial agents used in the control of periodontal biofilms: effective adjuncts to mechanical plaque control? Braz Oral Res. 2009;23 Suppl 1:39-48. doi: 10.1590/s1806-83242009000500007.
PMID: 19838557BACKGROUNDTsai TH, Tsai TH, Chien YC, Lee CW, Tsai PJ. In vitro antimicrobial activities against cariogenic streptococci and their antioxidant capacities: A comparative study of green tea versus different herbs. Food Chem. 2008 Oct 15;110(4):859-64. doi: 10.1016/j.foodchem.2008.02.085. Epub 2008 Mar 4.
PMID: 26047271BACKGROUNDTuresky S, Gilmore ND, Glickman I. Reduced plaque formation by the chloromethyl analogue of victamine C. J Periodontol. 1970 Jan;41(1):41-3. doi: 10.1902/jop.1970.41.41.41. No abstract available.
PMID: 5264376BACKGROUNDAbdulbaqi HR, Himratul-Aznita WH, Baharuddin NA. Evaluation of Salvadora persica L. and green tea anti-plaque effect: a randomized controlled crossover clinical trial. BMC Complement Altern Med. 2016 Dec 1;16(1):493. doi: 10.1186/s12906-016-1487-0.
PMID: 27903262DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nor_Adinar Baharuddin, DClinDent
University of Malaya
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 3, 2015
First Posted
December 8, 2015
Study Start
February 1, 2015
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
December 8, 2015
Record last verified: 2015-12
Data Sharing
- IPD Sharing
- Will not share